Rtw Investments, LP Ultragenyx Pharmaceutical Inc. Transaction History
Rtw Investments, LP
- $6.23 Billion
- Q1 2024
A detailed history of Rtw Investments, LP transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Rtw Investments, LP holds 7,087,115 shares of RARE stock, worth $291 Million. This represents 5.31% of its overall portfolio holdings.
Number of Shares
7,087,115
Previous 6,887,086
2.9%
Holding current value
$291 Million
Previous $329 Million
0.47%
% of portfolio
5.31%
Previous 5.41%
Shares
7 transactions
Others Institutions Holding RARE
# of Institutions
286Shares Held
78.6MCall Options Held
570KPut Options Held
228K-
Vanguard Group Inc Valley Forge, PA8.7MShares$358 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.24MShares$215 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.1MShares$168 Million0.03% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.86MShares$159 Million0.53% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.57MShares$147 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.88B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...